iShares Health Innovation Active ETF BMED

Medalist Rating as of | See BlackRock Investment Hub

Morningstar’s Analysis BMED

Will BMED outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares Health Innovation Active ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BMED

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 42.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Danaher Corp

5.19 706,160
Healthcare

Moderna Inc

5.02 682,964
Healthcare

Gilead Sciences Inc

5.00 679,475
Healthcare

AbbVie Inc

4.85 659,676
Healthcare

Thermo Fisher Scientific Inc

4.39 597,178
Healthcare

Johnson & Johnson

4.13 561,353
Healthcare

BlackRock Cash Funds Treasury SL Agency

4.12 560,000
Cash and Equivalents

Waters Corp

3.69 501,388
Healthcare

IQVIA Holdings Inc

3.65 496,346
Healthcare

Biogen Inc

3.51 477,622
Healthcare

Sponsor Center